Transitioning from multiple daily injections to a tubeless automated insulin delivery (AID) system significantly improves HbA1c in T1D.
Bayer today announced that its MEDRAD® Centargo multi-patient CT injector has secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the use of compatible contrast agent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results